# of Displayed Technologies: 10 / 18


Categories

Breaking the Cycle of Ehrlichiosis: A Novel RipE-Based Vaccine and Detection Platform
TS-072613 — A novel vaccine and diagnostic platform targeting the conserved Ehrlichia virulence factor RipE offers the first pan-Ehrlichia solution for preventing and detecting tick-borne ehrlichiosis in humans and animals.
Tick-borne ehrlichiosis cases continue to rise globally, yet no licensed human vaccine exists and current diagnostic tools remain limited. Existing approaches struggle due to the pathogen’s antigenic variability, intracellular lifecycle, and lack of classical surface PAMPs, hindering effecti…
  • College: College of Veterinary Medicine
  • Inventors: Rikihisa, Yasuko
  • Licensing Officer: Dahlman, Jason "Jay"

Innovative Small Molecule Inhibitors for Effective Treatment and Prevention of Coronavirus Infections
TS-066750 — The ongoing COVID-19 pandemic, caused by the SARS-CoV-2 virus, has significantly impacted global health and economies. Despite vaccine efforts, issues such as vaccine hesitancy, delays in distribution, and emerging variants have highlighted the need for effective therapeutic interventions. These i…
  • College: College of Veterinary Medicine
  • Inventors: Sharma, Amit; Li, Pui-Kai "Tom"; Xing, Enming
  • Licensing Officer: Willson, Christopher

Advancing Canine Lung Cancer Care: Precision Diagnostics and Targeted Therapies
TS-065859 — FIELD: Revolutionizing Canine Lung Cancer Treatment The Need: Lung cancer in canines poses significant clinical challenges, mirroring the complexities of human lung cancer in non-smokers. With limited standard treatments beyond surgery, there's an urgent demand for advanced methods to assess, c…
  • College: College of Veterinary Medicine
  • Inventors: Lorch, Gwendolen
  • Licensing Officer: Dahlman, Jason "Jay"

Live attenuated measles virus vaccine strains for SARS-CoV-2 vaccine
TS-065451 — The Need The need for effective vaccine development platforms has never been more pressing, especially in the face of evolving pathogens such as the measles virus. Current vaccine production methods often face challenges in achieving optimal expression levels and immunogenicity, hindering their eff…
  • College: College of Veterinary Medicine
  • Inventors: Li, Jianrong; Li, Anzhong; Liang, Xueya; Lu, Mijia; Niewiesk, Stefan
  • Licensing Officer: Willson, Christopher

CDP-choline a host-directed therapeutic for disease caused by SARS CoV-2 infection.
TS-064192 — The Need: The global impact of the SARS CoV-2 coronavirus has created an urgent need for innovative medical interventions to address the challenges posed by COVID-19. Despite the availability of vaccines, sub-optimal vaccine uptake and concerns about new virus variants necessitate additional medical…
  • College: College of Veterinary Medicine
  • Inventors: Davis, Ian; Schelhorn, Jean
  • Licensing Officer: Willson, Christopher

Introducing HexaPro VSV: A Breakthrough in COVID-19 Vaccine Technology
TS-064191 — The emergence of SARS-CoV-2 variants poses a significant challenge to existing COVID-19 vaccines, necessitating the development of a more durable and broadly protective solution. Current vaccines show reduced efficacy over time and struggle against Variants of Concern (VoCs) such as Omicron. Addre…
  • College: College of Veterinary Medicine
  • Inventors: Li, Jianrong; Chamblee, Michelle; Lu, Mijia; Zhang, Yuexiu
  • Licensing Officer: Willson, Christopher

A next generation intranasal trivalent Measles, Mumps and Covid vaccine
TS-064189 — The Need The current global landscape demands innovative solutions to address the urgent need for a safe and efficacious SARS-CoV-2 vaccine, particularly for the vulnerable population of infants and children under 12 years old. Existing vaccines face challenges in terms of durability, cost, and sta…
  • College: College of Veterinary Medicine
  • Inventors: Li, Jianrong; Xu, Jiayu; Zhang, Yuexiu
  • Licensing Officer: Willson, Christopher

Anaplasma Platys Diagnostics
TS-062349 — The Need In the veterinary field, there is a crucial need for accurate and specific diagnostic tests to identify and distinguish between Anaplasma platys (Apl) and other related pathogens like Anaplasma phagocytophilum (Aph). Current diagnostic methods lack specificity, leading to challenges in dif…
  • College: College of Veterinary Medicine
  • Inventors: Rikihisa, Yasuko
  • Licensing Officer: Dahlman, Jason "Jay"

Live Attenuated Mumps Virus-Based SARS-CoV-2 Vaccines for Infants and Children
TS-062231 — The Need: Addressing the Urgent Need for a Safe and Effective SARS-CoV-2 Vaccine for Infants and Children The ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has brought about significant economic, emotional, and public health challenges worldwide. The pressing dema…
  • College: College of Veterinary Medicine
  • Inventors: Li, Jianrong; Boyaka, Prosper; Lu, Mijia; Zhang, Yuexiu
  • Licensing Officer: Willson, Christopher

Addressing Tick-Borne Diseases with Advanced Therapeutic Interventions
TS-062227 — he Need: Tick-borne diseases, especially Human Monocytic Ehrlichiosis (HME), have become a significant public health concern in the United States due to their prevalence, life-threatening nature, and lack of effective treatment options. Current therapies are limited to the broad-spectrum antibiotic…
  • College: College of Veterinary Medicine
  • Inventors: Rikihisa, Yasuko; Zhang, Wenqing
  • Licensing Officer: Dahlman, Jason "Jay"

Show More Technologies

Loading icon